Effects of prenatal exposure to environmental estrogen and the development of endometriosis in adulthood [abstract] by Ghormley, Alison L.
Alison Ghormley, Biology 
Year in School: Senior 
Hometown: St. Louis, MO 
Faculty Mentor: Dr. Susan Nagel, Obstetrics, Gynecology, and Women's Health 
Funding Source: Life Sciences Undergraduate Research Opportunity Program  
 
Effects of prenatal exposure to environmental estrogen and the development of 
endometriosis in adulthood 
 
Endometriosis is an estrogen-dependent disease that affects 5% to 10% of all women, causing 
pain and infertility. This disease occurs when uterine tissue grows outside of the uterus in the 
body cavity. It is unknown what causes this tissue to grow outside of the uterus in some women 
and not in others. Studies have shown that other hormone-dependent diseases may be related to 
prenatal exposure to environmental chemicals, suggesting that the presence of different 
hormones before birth may alter the incidence of endometriosis in adulthood. For example, 
women whose mothers took the synthetic estrogen diethylstilbestrol (DES) during pregnancy had 
an 80% increased incidence of endometriosis. While pregnant women no longer take DES, there 
are compounds present in our environment that mimic estrogen action, and they can disturb the 
delicate balance of natural hormones in the body. These compounds are called endocrine 
disruptors, and they can be found in plastics, soy products, and some pesticides. The danger is 
that exposure to these environmental estrogens could increase the chance of developing estrogen-
dependent diseases such as endometriosis. Thus, our hypothesis is that prenatal exposure to 
environmental estrogen increases the severity of endometriosis in adulthood. To test this 
hypothesis, pregnant mice were dosed with either DES or oil (control). The offspring were then 
grown to adulthood. Endometriosis was surgically induced, and the mice were collected four 
weeks later to measure the severity of the disease. Developmental DES exacerbated 
endometriosis in this model: lesions from mice that were exposed to DES were twice as large as 
lesions from the control. We also found that developmental DES exposure permanently 
decreased the expression of TIMP-1, a gene known to inhibit endometriotic growth. At the 
conclusion of this ongoing study, we expect to 1) demonstrate an estrogen-mediated fetal 
component to endometriosis, 2) identify potential markers of fetal environmental estrogen 
exposure, and 3) potentially open the door to new therapeutic approaches to treat and prevent 
endometriosis. 
 
